Ticker Details
Co-Diagnostics, Inc. Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
IPO Date:	July 12, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.94M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.38%
Avg Daily Range (30 D):	$0.23 | 6.06%
Avg Daily Range (90 D):	$0.12 | 7.13%

Institutional Daily Volume
Avg Daily Volume:	.11M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	18
Avg Trade Size (Sh.) (30 D):	151
Avg Trade Size (Sh.) (90 D):	25

Institutional Trades
Total Institutional Trades:	366
Avg Institutional Trade:	$1.31M
Avg Institutional Trade (30 D):	$1.48M
Avg Institutional Trade (90 D):	$1.48M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.97M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.67K

News

Dec 30, 2025 @ 2:00 PM Co-Diagnostics Announces Reverse Stock Split Source: Prnewswire

Dec 8, 2025 @ 5:36 PM Co-Diagnostics JV, CoSara, to Participate at VIROC... Source: Prnewswire

Oct 22, 2025 @ 12:30 PM Co-Diagnostics Executive Leadership Team to Attend... Source: Prnewswire

Sep 18, 2025 @ 9:05 PM Co-Diagnostics, Inc. Announces Closing of $3.8 Mil... Source: Prnewswire

Aug 14, 2025 @ 8:19 PM Co-Diagnostics Sales Plunge 93 Percent Source: Jesterai

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.99	$-.16	$-.23
Diluted EPS	$-.98	$-.16	$-.23
Revenue	$.51M	$.15M	$.16M
Gross Profit	$.17M	$.12M	$.13M
Net Income / Loss	$-32.18M	$-5.89M	$-7.73M
Operating Income / Loss	$-35.53M	$-7.01M	$-8.06M
Cost of Revenue	$.34M	$.03M	$.03M
Net Cash Flow	$-11.98M	$M	$M
PE Ratio

Splits
Jan 02, 2026	1:30